Fatigue in Older Cancer Patients: Etiology, Assessment, and Treatment

Seminars in Oncology

Volumn 35, Issue 6, 2008, Pages 633-642

  Rao, Arati V ^a   Cohen, Harvey Jay ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DONEPEZIL; METHYLPHENIDATE; MODAFINIL; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BREAST CANCER; CANCER FATIGUE; CANCER PATIENT; CANCER RESEARCH; CANCER SURVIVAL; COLORECTAL CANCER; EXERCISE; HUMAN; LUNG CANCER; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; SENESCENCE;

AGED; FATIGUE; HUMANS; NEOPLASMS; QUALITY OF LIFE;

EID: 56249111997     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2008.08.005     Document Type: Article

References (56)

1. Cella D., Davis K., Breitbart W., et al. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19 (2001) 3385-3391
2. Mock V., Atkinson A., Barsevick A., et al. NCCN practice guidelines for cancer-related fatigue. Oncology 14 (2000) 151-161
3. Glaus A. Assessment of fatigue in cancer and non-cancer patients and in healthy individuals. Support Care Cancer 1 (1993) 305-315
4. Glaus A., Crow R., and Hammond S. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals. Eur J Cancer Care 5 Suppl (1996) 8-23
5. Inagaki M., Isono M., Okuyama T., et al. Plasma interleukin-6 and fatigue in terminally ill cancer patients. J Pain Symptom Manage 35 (2008) 153-161
6. Gutstein H.B. The biologic basis of fatigue. Cancer 92 Suppl (2001) 1678-1683
7. Stone P., Hardy J., Huddart R., et al. Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer 36 (2000) 1134-1141
8. Bower J.E., Ganz P.A., and Aziz N. Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom Med 67 (2005) 277-280
9. Bower J.E. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun 21 (2007) 863-871
10. Bower J.E., Ganz P.A., Aziz N., et al. T-cell homeostasis in breast cancer survivors with persistent fatigue. J Natl Cancer Inst 95 (2003) 1165-1168
11. Bower J.E., Ganz P.A., Aziz N., et al. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 64 (2002) 604-611
12. Harper P., and Littlewood T. Anaemia of cancer: impact on patient fatigue and long-term outcome. Oncology 69 Suppl 2 (2005) 2-7
13. Ancoli-Israel S., Moore P.J., and Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care 10 (2001) 245-255
14. Prue G., Rankin J., Allen J., et al. Cancer-related fatigue: a critical appraisal. Eur J Cancer 42 (2006) 846-863
15. Hann D.M., Garovoy N., Finkelstein B., et al. Fatigue and quality of life in breast cancer patients undergoing autologous stem cell transplantation: a longitudinal comparative study. J Pain Symptom Manage 17 (1999) 311-319
16. De Jong N., Candel MJ J.M., Schouten H.C., et al. Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol 16 (2005) 372-382
17. Reyes-Gibby C.C., Aday L.A., Anderson K.O., et al. Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage 32 (2006) 118-128
18. Hauser K, Rybicki L, Walsh D. Do pain depression fatigue cluster in advanced cancer. Presented at the Annual Meeting of Multinational Association of Supportive Care in Cancer, June 22-24, 2006, Toronto, Canada; abstract 28-217.
19. Respini D., Jacobsen P.B., Thors C., et al. The prevalence and correlates of fatigue in older cancer patients. Crit Rev Oncol Hematol 47 (2003) 273-279
20. Butt Z, Rao AV, Lai J, et al. Age-associated differences in fatigue among patients with cancer. Presented at the annual meeting of the Society of Behavioral Medicine, San Diego, CA, March 26-29, 2008.
21. Curt G.A. The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2. Oncologist 5 Suppl 2 (2000) 9-12
22. Curt G.A., Breitbart W., Cella D., et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5 (2000) 353-360
23. Jean-Pierre P., Figueroa-Moseley C.D., Kohli S., et al. Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist 12 Suppl 1 (2007) 11-21
24. Mendoza T.R., Wang X.S., Cleeland C.S., et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85 (1999) 1186-1196
25. Smets E.M., Garssen B., Bonke B., et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39 (1995) 315-325
26. Yellen S.B., Cella D.F., Webster K., et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13 (1997) 63-74
27. Carroll J.K., Kohli S., Mustian K.M., et al. Pharmacologic treatment of cancer-related fatigue. Oncologist 12 Suppl 1 (2007) 43-51
28. Gabrilove J.L., Cleeland C.S., Livingston R.B., et al. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 19 (2001) 2875-2882
29. Vadhan-Raj S., Mirtsching B., Charu V., et al. Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks. J Support Oncol 1 (2003) 131-138
30. Bruera E., Driver L., Barnes E.A., et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 21 (2003) 4439-4443
31. Bruera E., Valero V., Driver L., et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 24 (2006) 2073-2078
32. Lower E, Fleishman F, Cooper A, et al. A phase III randomized placebo-controlled trial of the safety and efficacy of d-MPH as a new treatment of fatigue and "chemo-brain" in adult cancer patients [abstract 8000]. Presented at the annual meeting of the American Society of Clinical Oncology, May 13-17, 2005, Orlando, FL.
33. Morrow G.R., Hickok J.T., Roscoe J.A., et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 21 (2003) 4635-4641
34. Wilcken NR, Goldstein D, Nowak AK, et al. A placebo-controlled trial of sertraline's effects on symptoms, well-being and survival in advanced cancer: the ZEST trial [abstract 9002]. Presented at the annual meeting of the American Society of Clinical Oncology, Chicago, IL, June 1-5, 2007.
35. Bruera E., El Osta B., Valero V., et al. Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 25 (2007) 3475-3481
36. Kaleita TA, Wellisch DK, Graham CA, et al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors. Presented at the annual meeting of the American Society of Clinical Oncology, June 2-6, 2006, Atlanta, GA; abstract 1503.
37. Morrow GR, Gilles LJ, Hickock JT, et al. The positive effect of the psychostimulant modafinil on fatigue from cancer that persists after treatment is completed [abstract 8012]. Presented at the annual meeting of the American Society of Clinical Oncology, May 13-17, 2005, Orlando, FL.
38. Bruera E., Roca E., Cedaro L., et al. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 69 (1985) 751-754
39. Mustian K.M., Morrow G.R., Carroll J.K., et al. Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist 12 Suppl 1 (2007) 52-67
40. Knols R., Aaronson N.K., Uebelhart D., et al. Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol 23 (2005) 3830-3842
41. Schmitz K.H., Holtzman J., Courneya K.S., et al. Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 14 (2005) 1588-1595
42. Courneya K.S., and Karvinen K.H. Exercise, aging, and cancer. Appl Physiol Nutr Metab 32 (2007) 1001-1007
43. Courneya K.S., Vallance J.K.H., McNeely M.L., et al. Exercise issues in older cancer survivors. Crit Rev Oncol Hematol 51 (2004) 249-261
44. Courneya K.S., Friedenreich C.M., Sela R.A., et al. The group psychotherapy and home-based physical exercise (group-hope) trial in cancer survivors: physical fitness and quality of life outcomes. Psychooncology 12 (2003) 357-374
45. Bower J.E., Woolery A., Sternlieb B., et al. Yoga for cancer patients and survivors. Cancer Control 12 (2005) 165-171
46. Roscoe J.A., Kaufman M.E., Matteson-Rusby S.E., et al. Cancer-related fatigue and sleep disorders. Oncologist 12 Suppl 1 (2007) 35-42
47. Savard J., Simard S., Giguere I., et al. Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: psychological and immunological effects. Palliat Support Care 4 (2006) 219-237
48. Barsevick A.M., Dudley W., Beck S., et al. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer 100 (2004) 1302-1310
49. Ryan J.L., Carroll J.K., Ryan E.P., et al. Mechanisms of cancer-related fatigue. Oncologist 12 Suppl 1 (2007) 22-34
50. Courneya K.S., Friedenreich C.M., Quinney H.A., et al. A randomized trial of exercise and quality of life in colorectal cancer survivors. Eur J Cancer Care 12 (2003) 347-357
51. Mock V., Dow K.H., Meares C.J., et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 24 (1997) 991-1000
52. Mock V., Pickett M., Ropka M.E., et al. Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract 9 (2001) 119-127
53. Dimeo F.C., Stieglitz R.D., Novelli-Fischer U., et al. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 85 (1999) 2273-2277
54. Dimeo F.C., Thomas F., Raabe-Menssen C., et al. Effect of aerobic exercise and relaxation training on fatigue and physical performance of cancer patients after surgery. A randomized controlled trial. Support Care Cancer 12 (2004) 774-779
55. Segal R.J., Reid R.D., Courneya K.S., et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21 (2003) 1653-1659
56. Windsor P.M., Nicol K.F., and Potter J. A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 101 (2004) 550-557